Sign in

You're signed outSign in or to get full access.

David F. Dalvey

Director at Celcuity
Board

About David F. Dalvey

Independent director since 2014 (age 66), Dalvey is a venture capitalist and corporate finance advisor with 30+ years working primarily with growth-oriented technology and life-science businesses; he is General Partner at Brightstone Venture Capital (since Sept. 2000) and holds a B.S. in Business/Management Economics from the University of Minnesota . He has completed over 150 corporate finance transactions and brings audit and investment community expertise to Celcuity’s Board; the Board deems him independent under Nasdaq rules .

Past Roles

OrganizationRoleTenureCommittees/Impact
Brightstone Venture CapitalGeneral PartnerSep 2000 – presentLed and managed ten venture partnerships; extensive board/advisor engagements
R.J. Steichen & Co.Management positions1995 – 2000Corporate finance advisory experience
The Food Fund LPManagement1992 – 1995Venture capital investing
Wessels, Arnold & HendersonInvestment banking1987 – 1992Corporate finance transactions
Navarre Corp. (now Speed Commerce)Director2009 – Nov 2012Board service
Blue Rock Market Neutral FundBoard of Managers2000 – 2014Mutual fund governance
Digitiliti, Inc.DirectorJul 2011 – Oct 2012Board service
Various private companies (HomeSpotter, Definity Health, AppTec Laboratories, CHF Solutions, Bite Squad, Agiliti, Nature Vision)Director/AdvisorVariousServed on audit, strategic or governance committees

External Roles

OrganizationRoleStatus/StartNotes
Brightstone Venture CapitalGeneral PartnerSep 2000 – presentVenture capital management company; raised and managed ten partnerships

Board Governance

  • Committee assignments: Audit Committee member; Compensation Committee member .
  • Audit Committee financial expert designation: Board determined Dalvey qualifies as an “audit committee financial expert” .
  • Independence: Board determined Dalvey is independent under Nasdaq Listing Rules .
  • Attendance and engagement: Board met five times in 2024; Audit Committee met five times; Compensation Committee met four times; all directors attended ≥75% of Board and committee meetings; all seven directors attended the 2024 annual meeting (in person or via video) .
  • Executive sessions: Audit Committee met in executive session once during 2024 .
  • Board leadership and oversight: CEO serves as Chairman; no lead independent director currently .
  • Conflicts policy: Audit Committee reviews and approves related party transactions under Nasdaq rules; no related party transactions requiring disclosure since Jan 1, 2023 (aside from items disclosed elsewhere) .
  • Hedging/pledging policy: Directors are prohibited from pledging Celcuity stock or engaging in hedging transactions; margin accounts are prohibited .
  • Clawback: Company adopted a clawback policy intended to comply with Nasdaq Rule 5608; Compensation Committee administers clawbacks for executives and directors .

Fixed Compensation

ComponentAmountTermsPeriod
Annual cash retainer$30,000 Payable quarterly Director compensation policy (May 2024–Apr 2025)
Cash paid (FY2024)$27,500 $6,250 for two quarters; $7,500 for two quarters FY2024
Equity grant (policy)$80,000 FMV RS or Options, at director’s election Annual award
FY2024 equity grant (Dalvey)Option award $80,000 8,153 options; exercise price $14.83; grant date 6/4/2024; 10-year term Vests 100% on 4/30/2025; then exercisable for remainder of term
Total FY2024 compensation$107,500 Cash + Option fair value (ASC 718) FY2024

Performance Compensation

MetricTargetActualWeightNotes
Director pay metricsNot disclosed Not disclosed Not disclosed Director equity awards in FY2024 vested time-based; no performance metrics disclosed for director awards

Other Directorships & Interlocks

CompanyTypeRoleTenureNotes
Navarre Corp. (Speed Commerce)PublicDirector2009 – Nov 2012Public company directorship
Digitiliti, Inc.PublicDirectorJul 2011 – Oct 2012Public company directorship
Blue Rock Market Neutral FundRegistered fundBoard of Managers2000 – 2014Investment Company Act fund board
Various private companiesPrivateDirector/AdvisorVariousServed on audit/strategic/governance committees

Expertise & Qualifications

  • Financial and audit expertise: Audit Committee financial expert; deep experience in financial controls, reporting, and investment banking .
  • Venture capital and corporate finance: Over 30 years’ experience; completed 150+ transactions; GP at Brightstone since 2000 .
  • Education: B.S. in Business/Management Economics, University of Minnesota .

Equity Ownership

CategoryShares/Units% of OutstandingNotes
Total beneficial ownership309,991 shares <1% Includes options exercisable within 60 days
Options held75,666 shares n/aExercisable within 60 days of Mar 17, 2025
Restricted stock held9,325 shares (as of Dec 31, 2024) n/aAggregate RS as of FY-end
Indirect holdings225,000 shares via Brightstone Venture Capital Fund, LP (Mr. Dalvey is GP) n/aIncluded in beneficial ownership
Anti-hedging/pledgingProhibited for directors PolicyInsider trading policy

Governance Assessment

  • Strengths: Independent director serving on Audit and Compensation Committees; designated audit committee financial expert, supporting oversight of financial reporting and compensation policy . Equity-heavy director pay (annual $80,000 grant) plus anti-hedging/pledging policy suggest alignment with long-term shareholder interests; FY2024 option grant vests within one year and carries a 10-year term, promoting long-term exposure .
  • Attendance and engagement: Board and key committees met regularly in 2024; all directors achieved ≥75% attendance, and the Audit Committee held an executive session, indicating active oversight .
  • Potential conflicts: Dalvey’s indirect ownership through Brightstone (225,000 shares) is disclosed; no related-party transactions involving him were reported since Jan 1, 2023; Audit Committee oversees related-person transactions .
  • Red flags: Board lacks a lead independent director despite CEO also serving as Chairman, which can concentrate power; family relationship exists between CEO (Brian Sullivan) and CSO/director (Lance Laing), requiring robust independent oversight .
  • Protections and policies: Clawback policy compliant with Nasdaq Rule 5608 applies to executives and directors; director equity awards accelerate upon corporate transaction/Change in Control, which is standard but warrants monitoring of potential windfalls .

Overall, Dalvey’s independence, committee roles, and financial expertise support board effectiveness; disclosed ownership suggests skin-in-the-game without hedging/pledging. Key governance watchpoints are the absence of a lead independent director and the family tie on the board, elevating the importance of independent committee rigor .